SBC Medical Group Holdings Incorporated (SBC) Operating Margin
- Operating margin · 12 months: Value 37.34%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 37.34% | Operating income / revenue. Period ending 2026-06-30. $65.41M ÷ $175.17M × 100 ≈ 37.34% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 65.41M USD | Operating Income (Loss) |
| Revenue | 175.17M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 60.45M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65.41M | $175.17M | (m) | (m) | $60.45M | 37.34% |
| 2026-03-31 | $61.00M | $169.34M | (m) | (m) | $58.89M | 36.02% |
| 2025-12-31 | $67.49M | $173.61M | (m) | (m) | $59.80M | 38.87% |
| 2025-09-30 | $59.36M | $178.46M | (m) | (m) | $57.60M | 33.26% |
| 2025-06-30 | $57.31M | $188.19M | (m) | (m) | $59.46M | 30.45% |
| 2025-03-31 | $70.04M | $197.94M | (m) | (m) | $56.14M | 35.39% |
| 2024-12-31 | $70.30M | $205.42M | (m) | (m) | $57.67M | 34.23% |
| 2024-09-30 | $17.14M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $-1.92M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $-1.89M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-1.77M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |